chr13-42953958-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_033255.5(EPSTI1):c.553C>A(p.His185Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000335 in 1,612,196 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_033255.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EPSTI1 | NM_033255.5 | c.553C>A | p.His185Asn | missense_variant | 6/11 | ENST00000313624.12 | NP_150280.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EPSTI1 | ENST00000313624.12 | c.553C>A | p.His185Asn | missense_variant | 6/11 | 1 | NM_033255.5 | ENSP00000318643.7 |
Frequencies
GnomAD3 genomes AF: 0.000171 AC: 26AN: 152194Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000481 AC: 12AN: 249716Hom.: 0 AF XY: 0.0000296 AC XY: 4AN XY: 134996
GnomAD4 exome AF: 0.0000192 AC: 28AN: 1460002Hom.: 0 Cov.: 30 AF XY: 0.0000138 AC XY: 10AN XY: 726318
GnomAD4 genome AF: 0.000171 AC: 26AN: 152194Hom.: 0 Cov.: 33 AF XY: 0.000148 AC XY: 11AN XY: 74352
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 24, 2024 | The c.553C>A (p.H185N) alteration is located in exon 6 (coding exon 6) of the EPSTI1 gene. This alteration results from a C to A substitution at nucleotide position 553, causing the histidine (H) at amino acid position 185 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at